Electron Capital Partners LLC trimmed its holdings in shares of Cognex Corporation (NASDAQ:CGNX – Free Report) by 38.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 852,984 shares of the scientific and technical instruments company’s stock after selling 532,958 shares during the quarter. Cognex makes up approximately 1.4% of Electron Capital Partners LLC’s investment portfolio, making the stock its 25th largest position. Electron Capital Partners LLC’s holdings in Cognex were worth $30,690,000 as of its most recent SEC filing.
Several other large investors have also made changes to their positions in CGNX. Geneos Wealth Management Inc. raised its stake in shares of Cognex by 402.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after buying an additional 736 shares during the period. CIBC Private Wealth Group LLC raised its stake in shares of Cognex by 74.8% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock worth $35,000 after buying an additional 327 shares during the period. Miller Global Investments LLC acquired a new position in shares of Cognex during the 4th quarter worth approximately $39,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Cognex during the 4th quarter worth approximately $39,000. Finally, Larson Financial Group LLC raised its stake in shares of Cognex by 202.7% during the 4th quarter. Larson Financial Group LLC now owns 1,105 shares of the scientific and technical instruments company’s stock worth $40,000 after buying an additional 740 shares during the period. 88.12% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Cognex news, VP Darren Marc Long sold 20,252 shares of the firm’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $66.34, for a total value of $1,343,517.68. Following the completion of the sale, the vice president directly owned 3,990 shares of the company’s stock, valued at $264,696.60. This trade represents a 83.54% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Mark Fennell sold 64,873 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $67.05, for a total value of $4,349,734.65. Following the completion of the sale, the insider directly owned 11,263 shares of the company’s stock, valued at $755,184.15. This trade represents a 85.21% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 224,847 shares of company stock valued at $14,975,098 in the last three months. 1.70% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on Cognex
Cognex Stock Performance
NASDAQ CGNX opened at $64.77 on Thursday. The business has a fifty day moving average price of $60.66 and a 200 day moving average price of $50.02. Cognex Corporation has a one year low of $29.22 and a one year high of $71.90. The company has a market cap of $10.78 billion, a P/E ratio of 77.11 and a beta of 1.52.
Cognex (NASDAQ:CGNX – Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.25 by $0.09. Cognex had a return on equity of 10.89% and a net margin of 13.62%.The firm had revenue of $268.44 million during the quarter, compared to the consensus estimate of $245.98 million. During the same period in the prior year, the company earned $0.14 EPS. The firm’s revenue was up 24.3% compared to the same quarter last year. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. As a group, sell-side analysts predict that Cognex Corporation will post 1.41 EPS for the current fiscal year.
Cognex Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, June 4th. Shareholders of record on Thursday, May 21st were paid a $0.085 dividend. The ex-dividend date of this dividend was Thursday, May 21st. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.5%. Cognex’s dividend payout ratio (DPR) is 40.48%.
Cognex Profile
Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.
The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.
Featured Articles
- Five stocks we like better than Cognex
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX – Free Report).
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.
